Russia: a medtech market in transition, but there is growth ahead
This article was originally published in Clinica
Executive Summary
The new regulatory system for medical devices in Russia will lead to improvements all round, but industry needs more guidance at present. So says Vladimir Sokov, a senior partner and head of corporate division at Moscow-based legal firm Pepeliaev Group*. In this interview with Ashley Yeo, he describes the new regulatory processes and explains that the market’s flatness at present is more to do with internal government issues than geopolitical unrest